Klein Lawrence Otto — SEC insider filings

SEC reporting owner CIK 1762583. 29 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-09-23 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CRISPR Therapeutics AG (CRSP)CBO & COO12—15 legs · 125,000 sh · $18,185,18039
Oruka Therapeutics, Inc. (ORKA)Chief Executive Officer, Director8—14 legs · 130,910 sh · $11,794,7859
Dyne Therapeutics, Inc. (DYN)Director4——8
Jasper Therapeutics, Inc. (JSPR)Director3——3
Jade Biosciences, Inc. (JBIO)Director2——2

Insider filings — Klein Lawrence Otto

FiledFormIssuerReported transactionsSource
2026-11-024Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 25,000 @ $7.80 · Sale (S): 6,466 @ $94.77 · Sale (S): 15,036 @ $95.64 · Sale (S): 2,442 @ $96.70 · Sale (S): 756 @ $97.45 · Sale (S): 300 @ $98.40 · +1 moreEDGAR
2026-10-024Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 25,000 @ $7.80 · Sale (S): 16,246 @ $83.40 · Sale (S): 8,554 @ $84.03 · Sale (S): 200 @ $84.78 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2026-09-154Oruka Therapeutics, Inc. (ORKA)Sale (S): 2,452 @ $95.71EDGAR
2026-09-014Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 75,000 @ $7.80 · Sale (S): 6,604 @ $90.79 · Sale (S): 63,596 @ $91.90 · Sale (S): 4,800 @ $92.44 · Option exercise (M): 75,000 (derivative) @ $0EDGAR
2026-06-154Oruka Therapeutics, Inc. (ORKA)Sale (S): 1,729 @ $69.69EDGAR
2026-06-114Jade Biosciences, Inc. (JBIO)Grant/award (A): 34,843 (derivative) @ $0EDGAR
2026-03-174Oruka Therapeutics, Inc. (ORKA)Sale (S): 1,729 @ $41.30EDGAR
2026-01-234Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 76,700 @ $0 · Grant/award (A): 306,700 (derivative) @ $0EDGAR
2025-05-014Jade Biosciences, Inc. (JBIO)Grant/award (A): 23,017 (derivative) @ $0EDGAR
2025-01-244Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-06-084Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 47,000 (derivative) @ $0EDGAR
2022-10-134Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 24,500 @ $0EDGAR
2022-08-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2022-07-064Dyne Therapeutics, Inc. (DYN)Grant/award (A): 7,222 (derivative) @ $0EDGAR
2022-06-064Dyne Therapeutics, Inc. (DYN)Grant/award (A): 19,596 (derivative) @ $0EDGAR
2022-03-234Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 78,045 (derivative) @ $0EDGAR
2022-03-144CRISPR Therapeutics AG (CRSP)Option exercise (M): 4,584 · Tax withholding (F): 1,883 @ $62.56 · Option exercise (M): 3,000 · Tax withholding (F): 1,229 @ $61.08 · Option exercise (M): 4,584 (derivative) · Option exercise (M): 3,000 (derivative)EDGAR
2022-02-224CRISPR Therapeutics AG (CRSP)Grant/award (A): 46,200 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2021-12-074CRISPR Therapeutics AG (CRSP)Option exercise (M): 26,667 · Tax withholding (F): 11,185 @ $69.17 · Option exercise (M): 26,667 (derivative)EDGAR
2021-10-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 13,800 (derivative) @ $0EDGAR
2021-09-144CRISPR Therapeutics AG (CRSP)Option exercise (M): 10,000 · Tax withholding (F): 4,207 @ $117.86 · Tax withholding (F): 10,000 (derivative)EDGAR
2021-05-274Dyne Therapeutics, Inc. (DYN)Grant/award (A): 19,596 (derivative) @ $0EDGAR
2021-03-254CRISPR Therapeutics AG (CRSP)Option exercise (M): 12,000 @ $44.67 · Option exercise (M): 22,000 @ $51.49 · Option exercise (M): 10,000 @ $29.87 · Option exercise (M): 20,000 @ $40.87 · Option exercise (M): 12,000 @ $14.43 · Option exercise (M): 12,000 @ $17.66 · +8 moreEDGAR
2021-03-124/ACRISPR Therapeutics AG (CRSP)Option exercise (M): 16,334 @ $14.43EDGAR
2021-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 4,583 · Tax withholding (F): 2,141 @ $124.15 · Grant/award (A): 33,334 (derivative) @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-01-204CRISPR Therapeutics AG (CRSP)Option exercise (M): 8,666 @ $12.57 · Sale (S): 2,911 @ $211.44 · Sale (S): 2,555 @ $212.54 · Sale (S): 1,200 @ $213.71 · Sale (S): 1,400 @ $214.46 · Sale (S): 400 @ $216.24 · +11 moreEDGAR
2021-01-044CRISPR Therapeutics AG (CRSP)Tax withholding (F): 9,392 @ $153.11EDGAR
2020-10-064CRISPR Therapeutics AG (CRSP)Grant/award (A): 16,666 (derivative) @ $0EDGAR
2020-09-234Dyne Therapeutics, Inc. (DYN)Conversion (C): 10,725 · Grant/award (A): 11,156 (derivative) @ $0 · Grant/award (A): 14,444 (derivative) @ $0 · Purchase (P): 35,574 (derivative) @ $2.81 · Conversion (C): 35,574 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762583 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs